Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML

Clinical trial NCT02073838 · COMPLETED

Trial details

NCT number: NCT02073838
Sponsor: Sarit Assouline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2015-05-01
Primary completion: 2022-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.